NASDAQ:BCTX

Briacell Therapeutics Stock Predictions

etoro logo Buy BCTX
*Your capital is at risk
$3.31
+0.0400 (+1.22%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BCTX Prediction Chart

BCTX Predictions History

Latest community submissions for BCTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 25, 2025 $5.68 -5.83% $5.20 V 90.80% 1
Apr 25, 2025 $5.81 -3.64% $5.20 V 88.26% 1
Apr 25, 2025 Bullish $5.20 X 0
Feb 20, 2025 $4.91 -5.11% $5.07 V 96.76% 1
Feb 20, 2025 $5.00 -3.20% $5.07 V 98.71% 2
Feb 20, 2025 Bullish $5.07 X 0
Feb 18, 2025 $4.10 -5.86% $5.09 X 80.46% 0
Feb 18, 2025 $4.19 -3.66% $5.09 X 82.33% 0
Feb 18, 2025 Bullish $5.09 V 1
Feb 3, 2023 $7.02 -93.15% $7.07 X 99.30% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BCTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BRIACELL THERAPEUTICS CORP.
BriaCell Therapeutics
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immun...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE